Results 161 to 170 of about 22,079 (282)

In vivo differentiation of scarring alopecia using line‐field confocal optical coherence tomography: a pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Diagnosing cicatricial alopecia is challenging. Even with histology, a definitive diagnosis cannot always be made. Line‐field confocal optical coherence tomography (LC‐OCT), a non‐invasive imaging method with high resolution used in vivo, has proven helpful in diagnosing scarring alopecia.
Marie‐Christine Nutz, Julia Welzel, Daniela Hartmann, Lars E. French, Maximilian Deußing, Elke C. Sattler   +5 more
wiley   +1 more source

Development of a Neural-Fuzzy-Based Variable Admittance Control Strategy for an Upper Limb Rehabilitation Exoskeleton. [PDF]

Sensors (Basel)
Shi Y, Li K, Zhang Y, Wu Q.
europepmc   +1 more source

Age‐specific melanoma risk associated with nevi: a pooled analysis from the M‐SKIP project

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Objective This study investigates the association of melanoma risk with total‐body nevus count and the presence of atypical nevi in younger (< 40 years) and older (> 60 years) individuals. Methods A pooled analysis was conducted within the M‐SKIP project, based on multiple melanoma case‐control studies.
Giulia Doi, Aurora Gaeta, Simone Ribero, Nelleke Gruis, Julia Newton‐Bishop, David Polsky, DeAnn Lazovich, Paola Ghiorzo, Gloria Ribas, Chiara Menin, Alexander J. Stratigos, Gabriella Guida, Susana Puig, Maria Concetta Fargnoli, Peter A. Kanetsky, Paola Queirolo, Vincenzo Bagnardi, Veronique Bataille, Sara Raimondi, Sara Gandini, M‐SKIP study group   +20 more
wiley   +1 more source

Matrix Quantum Mechanics and Entanglement Entropy: A Review. [PDF]

Entropy (Basel)
Fliss JR, Frenkel A.
europepmc   +1 more source

Testing the feasibility of an intermittent low‐energy diet in women with gestational diabetes

Diabetic Medicine, EarlyView.
Abstract Aims The study aimed to assess feasibility, acceptability and safety of an ILED in a randomised controlled trial of ILED vs. best NHS care healthy diet and exercise advice in women with Gestational Diabetes Mellitus (GDM) with body mass index ≥27.5 kg/m2 (≥25 kg/m2 in high‐risk minority ethnic groups) in the last trimester of pregnancy ...
Elizabeth Dapre, Emma Barrett, Brian McMillan, Andrea Pilkington, Fahmy Hanna, Avni Vyas, Cheryl Lombardelli, Womba Mubita, Jessy Athirampuzha, Liveen Dosanjh, Michelle Harvie, Basil G. Issa   +11 more
wiley   +1 more source

A lightweight, end-to-end explainable, and generalized attention-based graph neural network model trained on high-order spatiotemporal organization of dynamic functional connectivity to classify autistics from typically developing. [PDF]

Netw Neurosci
Bhavna K, Ghosh N, Banerjee R, Roy D.
europepmc   +1 more source

Psychosocial aspects of early detection in type 1 diabetes: Language matters, decision making and support needs

Diabetic Medicine, EarlyView.
Abstract Aim The potential implementation of early type 1 diabetes (T1D) detection pathways, encompassing autoantibody screening and longitudinal monitoring, raises important psychosocial considerations for ethical, person‐centred care. This review summarises evidence on the psychosocial impact of early T1D detection, identifying key evidence gaps and ...
Maartje de Wit, Laura Yvonne Klinker, Belinda Moore, Anna Boggiss, Lucía Feito Allonca, Mariam Asaad, Keely Bebbington, Bryan Cleal, Sasja Huisman, Per Winterdijk, Henk Jan Aanstoot, Christine Fransman, Elizabeth Holmes‐Truscott, Norbert Hermanns, Giesje Nefs   +14 more
wiley   +1 more source

The mosaic memory of large language models. [PDF]

Nat Commun
Shilov I, Meeus M, de Montjoye YA.
europepmc   +1 more source

Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley   +1 more source

Explainable Transfer Learning with Residual Attention BiLSTM for Prognosis of Ischemic Heart Disease. [PDF]

F1000Res
D C, N A, T PP, Ranganathan VA, Shailesh T, J A.   +5 more
europepmc   +1 more source